Bruker | BRKR - Selling And Administration Expenses


Bruker reported $242.1M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
ABB USD 1.68B 91M Mar/2026
Agilent USD 465M 11M Mar/2026
Ametek USD 202.62M 12.31M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Bruker USD 242.1M 5.1M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Danaher USD 1.86B 166M Mar/2026
Fujikura JPY 43.07B 8.08B Mar/2026
Furukawa JPY 5.2B 79M Dec/2025
General Electric Aerospace USD 1.08B 496M Mar/2026
Hitachi JPY 571.08B 79.7B Mar/2026
Illumina USD 272M 11M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Mitsubishi Electric JPY 324.81B 16.13B Dec/2025
Mitsubishi Heavy Industries JPY 180.66B 26.86B Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Nikon Corporation JPY 77.11B 2.47B Mar/2026
Olympus JPY 139.34B 13.69B Mar/2026
Repligen USD 76.54M 2.17M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Smiths GBP 79M 249M Jun/2026
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Waters USD 394M 153.99M Mar/2026